Virpax Pharmaceuticals, Inc. VRPX
Set alert
0.00 USD 0.00 0.00%
At close · Oct 29
0.45 +0.45 +56,125.00%
After hours · Oct 29, 4:00 PM ET
0.021 Day range 0.021
0.0001 52-week range 0.10
- YTD
- -92.79%
- 1 year
- -96.52%
- Open
- 0.021
- Prev close
- 0.0008
- Mkt cap
- 994
- Vol
- 51
- Avg vol
- 311
- EPS
- -5.12
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.021
- High
- 0.021
- Forward P/E
- -0.38
- Beta
- 1.09
- Short ratio
- 1.04
- Inst. own
- 1.90%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.54406
- 200-d avg
- 1.40
- 1y target
- 3.00
Financial health
Altman Z-Score
-90.71 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.1×
FY 2018 5y median -8.5× FY 2024
P/S 0.0×
FY 2018 5y median 0.0× FY 2024
P/B -44.2×
FY 2018 5y median 11.0× FY 2024
P/FCF -0.0×
FY 2018 5y median -10.2× FY 2024
EV/EBITDA -3.3×
FY 2018 5y median -3.3× FY 2024
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2024
FCF Yield -41351.3%
FY 2018 5y median -9.8% FY 2024
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2024
ROE 1320.6%
FY 2018 5y median -32.4% FY 2024
ROIC 1322.0%
FY 2018 5y median -32.1% FY 2024
ROA -775.7%
FY 2018 5y median -157.8% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2024
Operating Income 23.0%
FY 2018 FY 2024
EPS (diluted) -446.7%
FY 2018 FY 2024
Free Cash Flow -169509.2%
FY 2018 FY 2024
Financial Health
Current Ratio 0.6×
FY 2018 5y median 1.3× FY 2024
Quick Ratio 0.6×
FY 2018 5y median 1.3× FY 2024
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2024
Net Debt / EBITDA 0.1×
FY 2018 5y median 4.1× FY 2024
Interest Coverage -116×
FY 2018 5y median -28.4× FY 2024
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31